Safety and Immunogenicity of a Malaria Vaccine, Plasmodium falciparum AMA-1/MSP-1 Chimeric Protein Formulated in Montanide ISA 720 in Healthy Adults

BACKGROUND: The P. falciparum chimeric protein 2.9 (PfCP-2.9) consisting of the sequences of MSP1-19 and AMA-1 (III) is a malaria vaccine candidate that was found to induce inhibitory antibodies in rabbits and monkeys. This was a phase I randomized, single-blind, placebo-controlled, dose-escalation...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Jinhong, Chen, Zhihui, Gu, Jun, Wan, Mobin, Shen, Qian, Kieny, Marie-Paule, He, Jia, Li, Zhen, Zhang, Qingfeng, Reed, Zarifah Hussain, Zhu, Yongmei, Li, Wenjie, Cao, Yang, Qu, Li, Cao, Zhifang, Wang, Qiang, Liu, Haitao, Pan, Xuegong, Huang, Xiudong, Zhang, Dongmei, Xue, Xiangyang, Pan, Weiqing
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2276862/
https://www.ncbi.nlm.nih.gov/pubmed/18398475
http://dx.doi.org/10.1371/journal.pone.0001952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2276862/
https://www.ncbi.nlm.nih.gov/pubmed/18398475
http://dx.doi.org/10.1371/journal.pone.0001952

Ejemplares similares